Logo image of VRSK

VERISK ANALYTICS INC (VRSK) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:VRSK - US92345Y1064 - Common Stock

221.02 USD
-2.67 (-1.19%)
Last: 1/2/2026, 8:00:02 PM
221.02 USD
0 (0%)
After Hours: 1/2/2026, 8:00:02 PM
Fundamental Rating

6

Overall VRSK gets a fundamental rating of 6 out of 10. We evaluated VRSK against 86 industry peers in the Professional Services industry. VRSK scores excellent on profitability, but there are some minor concerns on its financial health. VRSK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

VRSK had positive earnings in the past year.
VRSK had a positive operating cash flow in the past year.
In the past 5 years VRSK has always been profitable.
In the past 5 years VRSK always reported a positive cash flow from operatings.
VRSK Yearly Net Income VS EBIT VS OCF VS FCFVRSK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

1.2 Ratios

Looking at the Return On Assets, with a value of 14.76%, VRSK belongs to the top of the industry, outperforming 93.02% of the companies in the same industry.
VRSK's Return On Equity of 244.62% is amongst the best of the industry. VRSK outperforms 100.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 25.82%, VRSK belongs to the top of the industry, outperforming 94.19% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for VRSK is significantly above the industry average of 11.86%.
Industry RankSector Rank
ROA 14.76%
ROE 244.62%
ROIC 25.82%
ROA(3y)16.75%
ROA(5y)13.64%
ROE(3y)403.34%
ROE(5y)252.02%
ROIC(3y)26.2%
ROIC(5y)20.62%
VRSK Yearly ROA, ROE, ROICVRSK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 200 400 600 800

1.3 Margins

Looking at the Profit Margin, with a value of 30.42%, VRSK belongs to the top of the industry, outperforming 96.51% of the companies in the same industry.
In the last couple of years the Profit Margin of VRSK has grown nicely.
VRSK has a better Operating Margin (44.61%) than 100.00% of its industry peers.
VRSK's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 69.62%, VRSK belongs to the top of the industry, outperforming 88.37% of the companies in the same industry.
VRSK's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 44.61%
PM (TTM) 30.42%
GM 69.62%
OM growth 3Y5.55%
OM growth 5Y9.03%
PM growth 3Y7.12%
PM growth 5Y14.02%
GM growth 3Y1.7%
GM growth 5Y1.91%
VRSK Yearly Profit, Operating, Gross MarginsVRSK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), VRSK is creating value.
VRSK has less shares outstanding than it did 1 year ago.
The number of shares outstanding for VRSK has been reduced compared to 5 years ago.
VRSK has a worse debt/assets ratio than last year.
VRSK Yearly Shares OutstandingVRSK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
VRSK Yearly Total Debt VS Total AssetsVRSK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 6.16 indicates that VRSK is not in any danger for bankruptcy at the moment.
VRSK's Altman-Z score of 6.16 is amongst the best of the industry. VRSK outperforms 89.53% of its industry peers.
The Debt to FCF ratio of VRSK is 4.23, which is a neutral value as it means it would take VRSK, 4.23 years of fcf income to pay off all of its debts.
VRSK has a Debt to FCF ratio of 4.23. This is comparable to the rest of the industry: VRSK outperforms 59.30% of its industry peers.
VRSK has a Debt/Equity ratio of 8.57. This is a high value indicating a heavy dependency on external financing.
VRSK's Debt to Equity ratio of 8.57 is on the low side compared to the rest of the industry. VRSK is outperformed by 87.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 8.57
Debt/FCF 4.23
Altman-Z 6.16
ROIC/WACC3.09
WACC8.35%
VRSK Yearly LT Debt VS Equity VS FCFVRSK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 1.19 indicates that VRSK should not have too much problems paying its short term obligations.
VRSK's Current ratio of 1.19 is on the low side compared to the rest of the industry. VRSK is outperformed by 65.12% of its industry peers.
A Quick Ratio of 1.19 indicates that VRSK should not have too much problems paying its short term obligations.
VRSK has a worse Quick ratio (1.19) than 65.12% of its industry peers.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 1.19
VRSK Yearly Current Assets VS Current LiabilitesVRSK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

6

3. Growth

3.1 Past

VRSK shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.76%.
VRSK shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.71% yearly.
The Revenue has been growing slightly by 7.30% in the past year.
Measured over the past years, VRSK shows a small growth in Revenue. The Revenue has been growing by 2.02% on average per year.
EPS 1Y (TTM)7.76%
EPS 3Y7.79%
EPS 5Y8.71%
EPS Q2Q%2.99%
Revenue 1Y (TTM)7.3%
Revenue growth 3Y5.38%
Revenue growth 5Y2.02%
Sales Q2Q%5.93%

3.2 Future

Based on estimates for the next years, VRSK will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.98% on average per year.
The Revenue is expected to grow by 8.19% on average over the next years. This is quite good.
EPS Next Y6.01%
EPS Next 2Y8.12%
EPS Next 3Y9.35%
EPS Next 5Y11.98%
Revenue Next Year6.54%
Revenue Next 2Y7.63%
Revenue Next 3Y7.34%
Revenue Next 5Y8.19%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
VRSK Yearly Revenue VS EstimatesVRSK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B 4B 5B
VRSK Yearly EPS VS EstimatesVRSK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5 10 15

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 31.85, the valuation of VRSK can be described as expensive.
VRSK's Price/Earnings ratio is in line with the industry average.
VRSK is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.60, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 28.43 indicates a quite expensive valuation of VRSK.
Based on the Price/Forward Earnings ratio, VRSK is valued a bit more expensive than 60.47% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.23. VRSK is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 31.85
Fwd PE 28.43
VRSK Price Earnings VS Forward Price EarningsVRSK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

VRSK's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as VRSK.
Industry RankSector Rank
P/FCF 27.61
EV/EBITDA 19.94
VRSK Per share dataVRSK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates VRSK does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of VRSK may justify a higher PE ratio.
PEG (NY)5.3
PEG (5Y)3.66
EPS Next 2Y8.12%
EPS Next 3Y9.35%

5

5. Dividend

5.1 Amount

VRSK has a yearly dividend return of 0.80%, which is pretty low.
Compared to an average industry Dividend Yield of 1.54, VRSK pays a bit more dividend than its industry peers.
With a Dividend Yield of 0.80, VRSK pays less dividend than the S&P500 average, which is at 1.94.
Industry RankSector Rank
Dividend Yield 0.8%

5.2 History

On average, the dividend of VRSK grows each year by 9.31%, which is quite nice.
VRSK has been paying a dividend for over 5 years, so it has already some track record.
VRSK has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)9.31%
Div Incr Years5
Div Non Decr Years5
VRSK Yearly Dividends per shareVRSK Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

26.40% of the earnings are spent on dividend by VRSK. This is a low number and sustainable payout ratio.
VRSK's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP26.4%
EPS Next 2Y8.12%
EPS Next 3Y9.35%
VRSK Yearly Income VS Free CF VS DividendVRSK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
VRSK Dividend Payout.VRSK Dividend Payout, showing the Payout Ratio.VRSK Dividend Payout.PayoutRetained Earnings

VERISK ANALYTICS INC

NASDAQ:VRSK (1/2/2026, 8:00:02 PM)

After market: 221.02 0 (0%)

221.02

-2.67 (-1.19%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)10-29 2025-10-29/bmo
Earnings (Next)02-24 2026-02-24/amc
Inst Owners96.8%
Inst Owner Change0.01%
Ins Owners0.24%
Ins Owner Change-0.34%
Market Cap30.80B
Revenue(TTM)3.03B
Net Income(TTM)921.50M
Analysts73.85
Price Target256.87 (16.22%)
Short Float %2.35%
Short Ratio2.12
Dividend
Industry RankSector Rank
Dividend Yield 0.8%
Yearly Dividend1.56
Dividend Growth(5Y)9.31%
DP26.4%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.54%
Min EPS beat(2)-0.97%
Max EPS beat(2)4.04%
EPS beat(4)2
Avg EPS beat(4)0.67%
Min EPS beat(4)-1.16%
Max EPS beat(4)4.04%
EPS beat(8)5
Avg EPS beat(8)1.1%
EPS beat(12)9
Avg EPS beat(12)3.34%
EPS beat(16)11
Avg EPS beat(16)2.55%
Revenue beat(2)0
Avg Revenue beat(2)-2.21%
Min Revenue beat(2)-2.95%
Max Revenue beat(2)-1.47%
Revenue beat(4)0
Avg Revenue beat(4)-1.92%
Min Revenue beat(4)-2.95%
Max Revenue beat(4)-1.47%
Revenue beat(8)0
Avg Revenue beat(8)-1.8%
Revenue beat(12)3
Avg Revenue beat(12)-6.31%
Revenue beat(16)3
Avg Revenue beat(16)-9.59%
PT rev (1m)-0.46%
PT rev (3m)-17.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.35%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.3%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-1.67%
Valuation
Industry RankSector Rank
PE 31.85
Fwd PE 28.43
P/S 10.17
P/FCF 27.61
P/OCF 22.85
P/B 81.77
P/tB N/A
EV/EBITDA 19.94
EPS(TTM)6.94
EY3.14%
EPS(NY)7.77
Fwd EY3.52%
FCF(TTM)8.01
FCFY3.62%
OCF(TTM)9.67
OCFY4.38%
SpS21.74
BVpS2.7
TBVpS-13.99
PEG (NY)5.3
PEG (5Y)3.66
Graham Number20.54
Profitability
Industry RankSector Rank
ROA 14.76%
ROE 244.62%
ROCE 33.93%
ROIC 25.82%
ROICexc 54.84%
ROICexgc N/A
OM 44.61%
PM (TTM) 30.42%
GM 69.62%
FCFM 36.83%
ROA(3y)16.75%
ROA(5y)13.64%
ROE(3y)403.34%
ROE(5y)252.02%
ROIC(3y)26.2%
ROIC(5y)20.62%
ROICexc(3y)28.25%
ROICexc(5y)22.06%
ROICexgc(3y)94.02%
ROICexgc(5y)202.88%
ROCE(3y)34.43%
ROCE(5y)27.1%
ROICexgc growth 3Y-34.19%
ROICexgc growth 5Y-20.39%
ROICexc growth 3Y41.96%
ROICexc growth 5Y27.35%
OM growth 3Y5.55%
OM growth 5Y9.03%
PM growth 3Y7.12%
PM growth 5Y14.02%
GM growth 3Y1.7%
GM growth 5Y1.91%
F-Score7
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 8.57
Debt/FCF 4.23
Debt/EBITDA 1.93
Cap/Depr 71.65%
Cap/Sales 7.67%
Interest Coverage 8.81
Cash Conversion 80.45%
Profit Quality 121.09%
Current Ratio 1.19
Quick Ratio 1.19
Altman-Z 6.16
F-Score7
WACC8.35%
ROIC/WACC3.09
Cap/Depr(3y)78.57%
Cap/Depr(5y)74.92%
Cap/Sales(3y)9.12%
Cap/Sales(5y)9.42%
Profit Quality(3y)104.47%
Profit Quality(5y)112.38%
High Growth Momentum
Growth
EPS 1Y (TTM)7.76%
EPS 3Y7.79%
EPS 5Y8.71%
EPS Q2Q%2.99%
EPS Next Y6.01%
EPS Next 2Y8.12%
EPS Next 3Y9.35%
EPS Next 5Y11.98%
Revenue 1Y (TTM)7.3%
Revenue growth 3Y5.38%
Revenue growth 5Y2.02%
Sales Q2Q%5.93%
Revenue Next Year6.54%
Revenue Next 2Y7.63%
Revenue Next 3Y7.34%
Revenue Next 5Y8.19%
EBIT growth 1Y13.67%
EBIT growth 3Y11.23%
EBIT growth 5Y11.24%
EBIT Next Year35.96%
EBIT Next 3Y17.32%
EBIT Next 5Y15.6%
FCF growth 1Y38.8%
FCF growth 3Y1.22%
FCF growth 5Y4.48%
OCF growth 1Y27.5%
OCF growth 3Y-0.34%
OCF growth 5Y3.66%

VERISK ANALYTICS INC / VRSK FAQ

What is the fundamental rating for VRSK stock?

ChartMill assigns a fundamental rating of 6 / 10 to VRSK.


What is the valuation status of VERISK ANALYTICS INC (VRSK) stock?

ChartMill assigns a valuation rating of 2 / 10 to VERISK ANALYTICS INC (VRSK). This can be considered as Overvalued.


What is the profitability of VRSK stock?

VERISK ANALYTICS INC (VRSK) has a profitability rating of 9 / 10.


Can you provide the PE and PB ratios for VRSK stock?

The Price/Earnings (PE) ratio for VERISK ANALYTICS INC (VRSK) is 31.85 and the Price/Book (PB) ratio is 81.77.


Can you provide the financial health for VRSK stock?

The financial health rating of VERISK ANALYTICS INC (VRSK) is 5 / 10.